chr1-13223606-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001099850.2(PRAMEF18):c.1166C>T(p.Thr389Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T389R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099850.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000359 AC: 1AN: 278902Hom.: 0 Cov.: 4 AF XY: 0.00 AC XY: 0AN XY: 145194 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1166C>T (p.T389M) alteration is located in exon 3 (coding exon 3) of the PRAMEF18 gene. This alteration results from a C to T substitution at nucleotide position 1166, causing the threonine (T) at amino acid position 389 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at